INVESTOR RELATIONS CENTER
Evotec SE
Analyst Coverage
| Unternehmen |
Analyst |
Empfehlung |
Target price of Shares listed at Frankfurt Stock Exchange
(in EUR) |
Target Price of ADS listed at NASDAQ New York
(in USD) |
Datum of latest
Research Report |
| BofA |
Derik de Bruin |
UNDERPERFORM |
|
3.00 D |
06 November 2024 |
| Bryan Garnier & Co |
Bruno Bulic |
BUY |
22.00 € |
- |
10 July 2024 |
| Citigroup Inc. |
Peter Verdult |
BUY |
30.00 € |
- |
22 May 2024 |
| TD Cowen |
Brendan Smith |
BUY |
- |
10.00 D |
22 November 2024 |
| Deutsche Bank |
Falko Friedrichs |
SELL |
4.00 € |
- |
02 December 2024 |
| H.C. Wainwright & Co. |
Douglas Tsao |
BUY |
- |
8.00 D |
15 August 2024 |
| IntronHealth |
Naresh Chouhan |
SELL |
7.35 € |
- |
17 June 2024 |
| Jefferies |
Ben Jackson |
HOLD |
6.80 € |
3.80 D |
15 November 2024 |
| ODDO BHF |
Stephan Wulf |
NEUTRAL |
7.50 € |
- |
7 August 2024 |
| Royal Bank of Canada (RBC) |
Charles Weston |
OUTPERFOM |
11.60 € |
- |
22 November 2024 |
| Rx Securities |
Dr Samir Devani |
BUY |
12.00 € |
- |
06 November 2024 |
| Van Lanschot Kempen |
Sebastiaan van der Schoot |
BUY |
10.50 € |
- |
18 December 2024 |
| Warburg Research |
Dr Christian Ehmann |
BUY |
14.00 € |
- |
12 December 2024 |
| Average target price |
|
|
12.58 € |
6.20 D |
|